1. Home
  2. AXNX vs DEI Comparison

AXNX vs DEI Comparison

Compare AXNX & DEI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AXNX
  • DEI
  • Stock Information
  • Founded
  • AXNX 2012
  • DEI 1971
  • Country
  • AXNX United States
  • DEI United States
  • Employees
  • AXNX 797
  • DEI N/A
  • Industry
  • AXNX Medical/Dental Instruments
  • DEI Real Estate Investment Trusts
  • Sector
  • AXNX Health Care
  • DEI Real Estate
  • Exchange
  • AXNX Nasdaq
  • DEI Nasdaq
  • Market Cap
  • AXNX 3.6B
  • DEI 3.2B
  • IPO Year
  • AXNX N/A
  • DEI 2006
  • Fundamental
  • Price
  • AXNX $70.45
  • DEI $18.08
  • Analyst Decision
  • AXNX Hold
  • DEI Hold
  • Analyst Count
  • AXNX 8
  • DEI 7
  • Target Price
  • AXNX $71.00
  • DEI $16.71
  • AVG Volume (30 Days)
  • AXNX 391.7K
  • DEI 1.5M
  • Earning Date
  • AXNX 11-07-2024
  • DEI 11-04-2024
  • Dividend Yield
  • AXNX N/A
  • DEI 4.20%
  • EPS Growth
  • AXNX N/A
  • DEI N/A
  • EPS
  • AXNX N/A
  • DEI N/A
  • Revenue
  • AXNX $431,902,000.00
  • DEI $965,443,000.00
  • Revenue This Year
  • AXNX $25.35
  • DEI N/A
  • Revenue Next Year
  • AXNX $19.92
  • DEI N/A
  • P/E Ratio
  • AXNX N/A
  • DEI N/A
  • Revenue Growth
  • AXNX 26.08
  • DEI N/A
  • 52 Week Low
  • AXNX $55.09
  • DEI $11.08
  • 52 Week High
  • AXNX $70.75
  • DEI $19.59
  • Technical
  • Relative Strength Index (RSI)
  • AXNX 65.61
  • DEI 48.40
  • Support Level
  • AXNX $70.36
  • DEI $17.49
  • Resistance Level
  • AXNX $70.75
  • DEI $19.59
  • Average True Range (ATR)
  • AXNX 0.20
  • DEI 0.65
  • MACD
  • AXNX -0.02
  • DEI -0.06
  • Stochastic Oscillator
  • AXNX 62.50
  • DEI 28.10

About AXNX Axonics Inc.

Axonics Inc is a United States-based medical technology company. It focuses on developing and commercializing novel products for adults with bladder and bowel dysfunction, that include implantable SNM systems to treat urinary urge incontinence and urinary urgency frequency (UUF); a urethral bulking agent (Bulkamid) to treat female stress urinary incontinence. SNM therapy is predominantly used to treat patients with overactive bladder, fecal incontinence, and urinary retention. Geographically, the company generates majority of its revenue from United States and rest from International markets.

About DEI Douglas Emmett Inc.

Douglas Emmett Inc is a real estate investment trust that acquires, develops, and manages office and multifamily properties in Los Angeles, California and Honolulu, Hawaii in the U.S. The company focuses on owning assets in communities with large supply constraints, such as the affluent neighborhoods of Los Angeles. The vast majority of Douglas Emmett's real estate portfolio is comprised of office buildings in Los Angeles. Most of these assets are located in the areas of Sherman Oaks, Woodland Hills, and Beverly Hills in terms of total square feet. Douglas Emmett derives nearly all of its income in the form of rental revenue from tenants. The vast majority of this also comes from its Los Angeles office buildings. The company's major tenants are legal, financial, and entertainment firms.

Share on Social Networks: